The heterogeneous properties of dermal cell populations have been posited to contribute toward fibrotic, imperfect wound healing in mammals. Here we characterize an adult population of dermal fibroblasts that maintain an active Prrx1 enhancer which originally marked mesenchymal limb Currie et al.
Introduction
The skin is the largest organ and one with a crucial task: making a multifunctional barrier between internal organs and the outside environment. The regenerative capacity of the skin is essential to maintain its integrity. However, in adult skin wound healing typically results in scar tissue. In the search for therapies that enhance wound healing or reduce fibrosis, cellular heterogeneity has emerged as an added layer of complexity that profoundly shapes the outcome of wound responses (Driskell et al., 2013) . The heterogeneity of fibroblasts has been of particular importance, since these cells are the main actors during wound healing to produce either scarfree healing or unresolved fibrotic scars (Gurtner et al., 2008) . Central to this idea, is that mixed populations of cells may carry intrinsic differences in their response to wound-related signals or their capacity to reconstitute all the structures of the intact organ.
Several groups have identified fibroblast subgroups by a single or battery of molecular markers.
Cells derived from Engrailed-1 embryonic lineage (Rinkevich et al., 2015) or adult cells with Gli-1 + expression have been shown to contribute to wound fibrosis (Kramann et al., 2014) , while Wntdependent expansion of BLIMP1 + dermal cells can support de novo hair follicle formation during wound repair (Kretzschmar et al., 2014) . Ideally, such categorization would distinguish subpopulations, with higher regenerative or differentiation potential, that could be analyzed in isolation from fibrosis-associated cells. The final goal would be to amplify and recruit non-fibrotic populations during wound repair, or inversely, deter fibrotic cells from making contributions to wound healing.
To identify adult cells that retain a progenitor-like ability to participate in tissue formation, we looked at molecular markers that are present during organogenesis. One such marker is the transcription factor paired-related homeobox 1 (Prrx1 or Prx1), an early marker of lateral plate Currie et al. 4 mesoderm (LPM) that labels progenitors of nascent limb skeleton and soft connective tissue of the flank and limb. Additionally, Prrx1 is upregulated following salamander limb amputation as well as in anuran limb regeneration (Suzuki et al., 2005) . Transgenic mouse models of Prrx1 activity have relied on a specific enhancer that encompasses approximately 2.4kb upstream of the transcriptional start site (Logan et al., 2002) . In reporter lines, this enhancer was used to drive LacZ or Cre recombinase expression in embryonic lateral soft connective tissue, portions of craniofacial mesenchyme, and limb skeleton and connective tissue. A recent report has implicated a population of PRRX1 + cells in the regeneration of calvarial bone (Wilk et al., 2017) , but whether PRRX1 protein (PRRX1 + ) or enhancer activity (Prrx1 enh+ ) remain postnatally in other tissues is unknown. This led us to investigate Prrx1 expression and enhancer activity in the skin to determine its role in homeostasis and tissue repair.
Results and Discussion

PRRX1 protein marks a broad population of limb bud progenitors and adult mesenchymal dermal cells
Prrx1 was originally characterized as a progenitor marker of limb skeleton and soft connective tissue using a combination of in situ hybridization and Cre activity or LacZ expression in reporter mice (Chesterman et al., 2001 ). However, a precise timeline of protein expression at both embryonic and postnatal timepoints is unknown. To do this, we used a previously characterized polyclonal antibody anti-PRRX1 (Gerber et al., 2018; Oliveira et al., 2017) . By At E16.5, clear PRRX1 + and PRRX1 -zones were visible in the limb, although most connective tissue cells were still PRRX1 + (Figure 1 D) . We further investigated if PRRX1 remains in postnatal tissue or if its expression is restricted to embryonic and neonatal stages. In postnatal day 3 (P3) PRRX1 + cells persist abundantly in the dermis (Figure 1 E) . Since PDGFR⍺ has been previously suggested as a pan marker of dermal fibroblasts (Driskell et al., 2013) , we used the Pdgfr⍺-H2B-EGFP transgenic mouse to quantify the overlap of PRRX1 + in adult mesenchymal dermal tissue (Figure 1 F) . We found that in 7 week-old mice 12,7% ± 4,1 (n=6) of total PRRX1 + cells are PDGFR⍺ -. Conversely, 22,8% ± 10,1 of the total PDGFR⍺ + cells are PRRX1 - (Figure 1 G-H (Rinkevich et al., 2015) . Neither PRRX1 nor PDGFR⍺ encompassed the full complement of mesenchymal cells and PDGFR⍺ is also expressed in non-mesenchymal lineages such as megakaryocytes and platelets (Demoulin and Montano-Almendras, 2012; Ye et al., 2010) . Therefore, our data shows that PRRX1 is an optimal marker to demarcate a broad mesenchymal population in the dermis.
The Prrx1 enhancer labels embryonic mesenchymal progenitor cells and a small subset of the broad PRRX1 dermal cell population
To trace the fate of PRRX1 cells in homeostasis and injury, we generated transgenic mice expressing Cre-ERT under the control of the 2.4kb Prrx1 enhancer (Logan et al., 2002) 
Prrx1 enhancer cells are injury-responsive and amplify upon limb full-thickness skin wounding
We were curious if these limited Prrx1 enh+ cells in the adult mouse retained embryonic-like properties that could contribute positively to repair and regeneration. Previously, the mouse Prrx1 enhancer was shown to be active during wound healing and spike formation in Xenopus (Suzuki et al., 2007) , but absent in wound healing of mouse back skin (Yokoyama et al., 2011) , the predominant experimental paradigm for skin healing in the mouse. Although PRRX1 protein is present in dermal cells of back skin, we could detect no more than one or two Prrx1 enh+ cells in multiple sections of at least 4mm expanding along the back (Supp. Fig. 1 A) (n=10 animals). The lack of enhancer positive cells in back skin was confirmed after tamoxifen administration in embryos, adult mice, or after injury.
Given that the Prrx1 enhancer marks limb progenitors, and fibroblasts are known to carry unique positional information based on their location in different body parts, we decided to lineage trace Prrx1 enh+ cells in a limb full-thickness skin injury model. We performed 2mm full thickness skin wounds in the upper limbs of Prrx1enh-CreER;LSL-tdTomato (Supp. Fig. 1 B) . Mice were wounded three weeks after the last administration of tamoxifen to prevent recombination during wound healing. In contrast to back skin wounds, it was not possible to splint limb skin wounds. A semi-occlusive bandage (Tegaderm 3M) was applied for the first 48-60 hours to prevent infection. This bandage only mildly impedes wound contraction that is characteristic of skin wounds in rodents (Supp. Fig. 1 C) . Fourteen days post wounding (14 dpw), animals were sacrificed and the wounded and contralateral limb were compared for the percentage of Prrx1 enh+ (tdTOMATO + ) cells. At low magnification there was already an obvious amplification of Prrx1 enh+ cells within the wound bed compared with the adjacent wound margin and contralateral limb (Figure 3 A, B) . LSL-tdTomato) . This transgenic mouse has been used previously as a reporter of wound healing in dorsal wounds (Higashiyama et al., 2011; Rajkumar et al., 2006) . We administered tamoxifen 3 weeks before wounding and quantified tdTOMATO + cells in contralateral and wound tissue (Supp . Fig 2 A, B) . In uninjured tissue Col1a2 enh+ cells labeled dermal fibroblasts as well as portions of surface and interfollicular epithelia. No difference was found in the percentage of Col1a2 enh+ cells among the total of mesenchymal PRRX1 + cells, in injured and intact skin (Supp .   Fig 2 D) . In contrast to Prrx1 enh+ cells, we found no enrichment of positive dermal cells within the wound bed or in the subcutaneous space under the wounds (Supp . Fig 2 G, H) . In fact, there was a small depletion of Col1a2 enh+ /PRRX + within the wound 21 days after injury. This suggests that the dermal cells labeled by Col1a2 enh+ have a muted response to injury and may be slightly displaced by other subpopulations including Prrx1 enh+ cells. Prrx1 has been shown to be a marker necessary for maintaining stemness in adult hippocampal tissue (Shimozaki et al., 2013) . We hypothesized that cells expressing Prrx1 would contribute to wound repair by either providing daughter cells that would differentiate and directly contribute to structuring the wound, or by supplying factors that modulate healing.
In response to injury, dermal
As a marker of regenerative progenitors, Prrx1 upregulation has been viewed as a stereotypical step in the formation of the proliferative blastema during salamander limb regeneration . Recent lineage tracing in the axolotl showed that Prrx1 enh+ cells are multipotent cells that can regenerate skeleton and soft connective tissue (Gerber et al., 2018) . The molecular mechanism underlying the enrichment of Prrx1 enh+ cells within mouse skin wounds is unknown, but live imaging of connective tissue during axolotl regeneration uncovered a pivotal role of cell migration in the process of blastema cell creation (Currie et al., 2016) . It is tempting to think that activation of the Prrx1 enhancer could relate to an increased readiness or propensity to migrate, which could relate to the role of Prrx1 in epithelial to mesenchymal transitions (EMT) (Ocaña et al., 2012) . In this study, we show that the protein expression of Prrx1 differs from the activity of the 2.4kb upstream enhancer, and the results presented here argue for a subpopulation of enhancer versus PRRX1 + cells.
The heterogenous responses to healing by different fibroblastic populations is inarguably complex, and at least three sources could account for some aspects: 1) embryonic origin, 2) location in the body and 3) the microenvironment. One illustrating example is the different response to regeneration from fibroblasts in the P3 phalanx versus fibroblasts in the P2 phalanx (Wu et al., 2013) .
In this work we investigated the response of Prrx1 enhancer-expressing cells to injury and homeostasis. Because this enhancer is limb specific, we focused on full-thickness skin wounds in the limb. The majority of wound healing assays in murine models are based on back skin wounding due to the inaccessibility during grooming, the ability to make large wounds surpassing 5mm in diameter, and the possibility to splint (to mimic wound healing in humans where there is no contraction). The embryonic source of dorsal cells is diverse and could encompass cells from neural crest, pre-somitic mesoderm, and lateral plate mesoderm. In contrast, connective tissue of the limbs derives primarily from a single embryonic source of lateral plate mesoderm. In the future it will be interesting to assess if limb dermal cells display less heterogeneity compared to the dermal compartment of other regions that derive from diverse embryonic origins. In addition to being of a single embryonic source, experimental paradigms of wound healing in limbs have an important and clinical relevance for diabetic and trauma-related injuries.
One of the most surprising results was the wide contribution of Prrx1 enh+ cells to subcutaneous tissues under the wound bed. We administered Tamoxifen three weeks prior to wounding and never observed an enrichment of subcutaneous cells except in the context of wounding and did not observe a similar phenotype when labeling Col1a2 enh+ fibroblasts. This suggests to us that Prrx1 enh+ cells from the dermis emigrate into foreign subcutaneous tissues and contribute to adipocytes, fascia, and other structures. This resident tissue plasticity may be a conserved feature of Prrx1 enh+ cells, since axolotl Prrx1 enh+ cells are able to contribute to new segment formation in contrast to other mesenchymal cell populations (Gerber et al., 2018) . While Prrx1 enh+ cells are able to expand and contribute to healing tissue, they do not seem to play a role in normal tissue growth and homeostasis as is the case for most epithelial stem cell pools.
By labeling at several prenatal and early postnatal timepoints, we were unable to observe long term expansion of Prrx1 enh+ clones that might arise from a tissue resident stem cell. Instead, Prrx1 enh+ cells remained relatively quiescent during post-embryonic growth and restricted to the perivascular and dermal papilla niches. It was only post-injury that cells amplified during wound healing migration and proliferation. Our work suggests that Prrx1 enh+ cells represent a specialized pool of injury-responsive cells. Recent work has highlighted similar populations of cells that are specifically tuned for tissue repair but not tissue maintenance and growth (Llorens-Bobadilla et al., 2015; Lopez-Baez, 2018; Marecic et al., 2015) . It will be interesting in the future to understand what molecular factors drive the Prrx1 enhancer during injury and to what degree they overlap with regulators of embryonic Prrx1 enhancer activity. Based on the differences in Prrx1 enhancer activity and PRRX1 protein expression, we hypothesize that there may be distinct molecular differences that differentiate enhancer-positive cells from the broader PRRX1 population which manifests in large differences in cell behavior during wound repair.
Overall, our results highlight a unique injury-responsive cell population within adult tissue. As impressive as the response of Prrx1 enh+ cells to injury, their amplified numbers still make up only a small fraction of the overall population of wound fibroblasts. Future work aimed at understanding the molecular signals that retain and specify Prxx1 enh+ cells will be key to tipping the balance from scar formation to regenerative tissue replacement.
Materials and Methods
Transgenic mouse lines
A construct was created containing the 2.4kb mouse Prrx1 enhancer (REF) followed by the bglobin intron and nuclear-localized teal fluorescent protein-1 (mTFP1-nls), a T2A self-cleaving peptide, and CreERT2. The construct was linearized by digestion by KpnI and injected into the pro-nucleus of Bl6/J mouse oocytes (MPI-CBG Transgenic Core Facility). Six founder animals were generated and F1 progeny were screened for mTFP expression during embryonic limb development (E10.5-E12. 
Wounding
Animals were anesthetized by intraperitoneal injection of a mixture of Ketamine (100 mg/kg) and Xylazin (10 mg/kg). Skin was shaved, chemically defoliated, and wiped with 70% ethanol. To create a 2 mm wound in the forelimb, we pulled the skin from the posterior part of the limb (skin in the forelimb is not attached to the muscle-skeletal core) and at the crease, perforated with the half of a 2 mm punch biopsy. Wounds were immediately disinfected with iodine solution and wrapped with Tegaderm (3M) and bandage. Animals were given Carprofen at 4mg/kg and monitored during anesthetic recovery. Wounded animals were monitored daily for signs of infection and any self-removal of bandages. If animals had not removed forelimb bandages and Tegaderm by two to three days post wounding, the dressing was manually removed to synchronize the kinetics of wound resolution. The wound in the posterior area of the limb ensured that the mice were not able to reach it and affect the healing process. We did not observed infections or any complication due to the wound. Animals were sacrifice at either 5, 14, 21, or 28 days post wounding and skin was processed as described above.
Tissue dissociation and FACS Animals were sacrificed and upper arm skin was shaved and cut as full thickness skin. Adipose depots were manually removed, and the skin was washed once with 70% ethanol and three times with cold, sterile PBS. Skin was incubated in 10mg/ml elastase in DMEM at 37Cº for 20 minutes.
Dermal tissue was manually removed and separated from epithelial tissue. Dermal tissue pieces were then placed in 0.35mg/ml Liberase TM in PBS with 10 Units/µl DNase for 37Cº for 30 minutes and then manually dissociated by mechanical disruption with forceps to achieve a single cell suspension. Cell suspensions were filtered through a 50µm mesh and diluted in 10% serum containing DMEM. Cell suspensions were centrifuged at 900rcf and resuspended in serumcontaining DMEM. Both filtered cells and unfiltered tissue pieces were plated on gelatin coatedtissue culture plates. 24 hours post-dissociation both filtered cells and unfiltered tissue were visually assessed for tdTOMATO expression. 24-48 hours after dissociation, cells were trypsinized, washed, and resuspended in FACs buffer containing 1x PBS (Ca/Mg free), 2mM EDTA, 25mM Hepes (pH 7.2), 1% BSA, and pen/strep. Non-transgenic controls skin was used to determine gating for tdTOMATO signal.
Imaging
Images were acquired with a 20x objective Apotome 2 (Zeiss) or inverted laser scanning confocal 780 (Zeiss) at 20 or 40x magnification. Imaging was performed on instruments of the Light Microscopy Facility, a core facility of CRTD at Technische Universität Dresden. Images were analyzed using Fiji and Photoshop, and alterations to brightness or contrast were applied equally to the entire micrograph for visualization purposes only. Cell quantification was performed in two sections per wound, of the mid area, of each animal. A region of interest measuring 1mm 2 was cropped in Fiji for quantification. Wound sections were paired with their contralateral control to determine the fold increase and investigator was blinded to the sample grouping. Statistical analyses were performed using the Graphpad Prism 7.0 software.
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